We found significantly lower GAS7b mRNA expression level in the lymph-node metastatic tumors compared to their paired primary tumor samples (Fig. 7a), For IHC analysis, we used commercial tissue array to analyze GAS7 protein expression in clinical breast tumor samples (Fig. 7b). This evidence concerns the gene GAS7 and metastatic neoplasm.